BHARE Foundation

TAG DAYS 2017 !

This year TAG days will be on: April 22, May 20, June 24, August 12

Hitting the streets for 2017 TAG Days!
Hitting the streets for 2017 TAG Days!

 

BHARE Foundation supporters,

I am so pleased to report some exciting news.  If you have been following our path and reading the letters over the years, you know that our Foundation fully believes that dysfunctional GI and immune systems are the major contributing factors in autism.  If a diabetic has low blood sugar and is acting inappropriately, anyone medically trained should not think about brain scans, or giving medication to control disruptive and abnormal behaviors.  A trained professional would simply start an IV and administer a dextrose solution to bring the blood sugar level back to a normal range.  Within minutes, the diabetic is back to “normal”.  The individual is not cured, but is fully functional and the disease is manageable.

In last year’s letter I stated, “Studying the gut has been our most exciting and promising research.  Dr. Jim Adams, at Arizona State University, along with Dr. Rosa Krajmalnik-Brown and Daewook Kang, have published studies proving major differences in the total make up of types and groups of populations of bacteria in people with autism.”

In January 2017, the research I have been waiting to tell you about for a long time was finally published.  This ground breaking paper was published in the Journal Microbiome and can be read in full by going to bhare.org.

In summary, the team found a way to restore hundreds of beneficial bacteria that are missing in a large subgroup of people with autism.  In an 8 week treatment period, followed by 8 weeks of observation, 16 out of 18 subjects ages 7-16, improved their developmental age by 1.4 years.  By changing the flora in the GI tract, this treatment revealed how critical a role the gut bacteria play in contributing to or causing autism.  We have been part of a great team effort that has resulted in a major breakthrough, without the help of big money autism groups.

The study was small and will not be taken seriously until it is replicated with larger numbers of participants.  It must be double blind and placebo controlled.  Thus, we need your help more than ever before so that we can reach our ultimate goal.  The FDA will approve this as a treatment when research proves it works and is safe.  Certainly this small study and many other studies unrelated to autism, have proven that Fecal Microbial Transplant (FMT), or as the recent paper identifies the process as, Microbiota Transfer Therapy (MTT), is safe, effective and fairly non-invasive.

The team at ASU will be receiving a large grant from the government.  However, there are parts of the study that still need funding.  I have committed that the BHARE Foundation will raise the $128,000.00 that is still needed.  This represents the largest donation we would or have made in our 17 year history.  I think it is well worth the effort.  Please help us reach this goal by sending a check or donate now via PayPal.   Over 90% of what you donate, goes directly to research.  A donation of even $10 or $20 will help.  You do make a difference!

Thank you,

Bram Hornstein

The BHARE Foundation


First Steps Toward a Real Treatment for Autism.

Published in January 2017

The BHARE Foundation is pleased to note that they provided funding for basic scientific research to Profs. Adams and Krajmalnik-Brown, and that basic research provided critical data that helped justify the need for FMT and helped win FDA approval for the clinical trial.

Read the full study here: http://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-016-0225-7

Please take a moment to watch this short video explaining the study.

 


Folinic Acid Study

With your support, BHARE has been able to fund another positive study that was published this year. Please take a look at the tremendous effect you are creating by helping us fund research.

Folinic Acid Study